UAE approves gene replacement therapy for new age group in spinal muscular atrophy patients

Dec 20, 2025

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat...